Table 2

Influence of the screening programme

Cohort ACohort BP value
Number of biliary atresia cases5068
Patients who underwent Kasai procedure34 (68.0%)57 (83.8%)<0.05
Age at diagnosis ±SD (days)81±1256±15<0.05
Length of stay ±SD (days)49±2144±20<0.05
Medical fee ±SD (¥)48 850±12 38747 752±18 121<0.05
Jaundice-free16 (47.1%)31 (54.4%)<0.05
Postsurgical complications20 (58.8%)30 (52.6%)<0.05
Liver transplantation13 (38.2%)23 (40.4%)>0.05
2-year native liver survival rate15 (44.4%)30 (52.6%)<0.05
Death7 (20.6%)6 (10.5%)<0.05
Overall survival27 (79.4%)51 (89.5%)<0.05
  • Cohort A: patients diagnosed between 2013 and 2014 and born in Shenzhen; cohort B: patients diagnosed between 2015 and 2017 and born in Shenzhen.

  • ¥ is China’s monetary unit, and ¥1 is equal to US$0.14.

  • Overall survival was the sum total of patients who survived after liver transplantation and patients who survived with a native liver.